Navigation Links
Lost molecule holds the key to lung cancer

Lung cancer is soon becoming infamous with being the leading cause of cancer deaths in the world – what with nearly 1.2 million fresh cases every// year that includes more than 37,000 in the UK itself!

According to recent research, the most common type of lung cancer, owes its birth to the impairment of a single type of protein molecule. The researchers, from Vanderbilt University in Nashville, have expressed optimism with this finding, which will hold a clue to new treatments for non-small cell lung cancer. This study has found a place in the British Journal Of cancer.

The proteins help mange the growth of cells, the blood vessel formation and cell death, which can all get haywire when a person is afflicted with cancer. Samples of lung tumor tissue from nearly 46 lung cancer patients and similar numbers of lung tissue from healthy patients were compared by researchers, and the finding revealed that the important proteins were completely missing or showed a decline in their presence in nearly 75% of the tumor samples. The same processes were repeated on mice.

Lead researcher Professor Pran Datta said: "We've established for the first time that these important molecules are either missing or that their action is reduced in three quarters of all cases of lung cancer. When we restored the molecules in lung cancer cells in mice they reduced the ability of the cells to grow as tumors."

Professor John Toy, of Cancer Research UK, said: "Unraveling events that lead to the loss of normal molecules in cancer is extremely important in finding new ways to control the disease.However, it's important to remember that the vast majority of cases of lung cancer are preventable as they are caused by smoking. The best way to reduce risk is to quit."


'"/>




Page: 1

Related medicine news :

1. Poisonous Parkinsons molecule discovered
2. Glenmark’s new molecule to go through trial
3. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
4. Ways to counter radiation effects with new molecule discovery
5. Same molecule found in meat, milk, tumors
6. New molecule to treat brain disorders found
7. Cell molecules behind neuro degenerative diseases
8. New anti-aging molecule could be coming up in way
9. So now here might come a memory molecule!!!
10. THC molecule turns out to a boon for Alzheimer’s patient
11. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lost molecule holds the key lung cancer

(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...l Will Retain Decision Resources, Clinical Gold St... a New Report from Decision Resources , , WALTHAM...world,s leading research and advisory firms for ph...e attribute that most influences their prescribing...
...ws those who respond to lapatinib survive longer, ...he drug lapatinib could be used to treat aggressiv... of a phase 2 study. , Inflammatory breast cancer...apid onset of swelling, redness of breast skin, a ...
...ds they test higher than unmedicated peers in grad...ews) -- Children who take medication to treat atte...ter in elementary school than those who don,t, a n...h tests and 5.4 points higher on reading tests tha...
...nt Clinton supports global tribute to inspire peop...l 27 46664 and the Nelson Mandela Foundation are ...creation of an official Mandela Day , to be held ...heir individual power to make an imprint and help ...
...TON, April 27 A study of child development and un...SA is the first to link age-appropriate safety t...en,s cognitive, behavioral and physical developmen... parents how to keep their kids safe, but this rep...
...ly invasive varicose vein treatment market is larg...rch Group , , WALTHAM, Mass., April 27 According...ties in Brazil : Varicose Vein Treatment Devi...tment device market in the country, widely conside...
Other Medicine News:Health News:For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms 2Health News:For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms 3Health News:Drug May Help Against Inflammatory Breast Cancer 2Health News:Meds Help Kids With ADHD in Classroom 2Health News:Meds Help Kids With ADHD in Classroom 3Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 2Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 3Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 4Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 5Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 2Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 3Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 4Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 5Health News:Growth Opportunity in Brazil's Varicose Vein Treatment Device Market 2Health News:Growth Opportunity in Brazil's Varicose Vein Treatment Device Market 3
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases 28AASLD 29 14321 1Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases 28AASLD 29 14321 2Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases 28AASLD 29 14321 3URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 1URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 2URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 3URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 4PDL BioPharma Completes October 1 Special Dividend Payment 5167 1
...France, Sept. 11 NicOx S.A.,(Eurolist: COX) today...sclosed promising top-line results from its first ...l entity licensed from NicOx which is a novel,resp... good safety and,tolerability profile, in addition...be beneficial in TOPIGEN,s target indication of Ch...
...1 S*BIO Pte Ltd today announced the,development o...ound,SB1518, for the treatment of myeloproliferati...nancies. MPD is believed to be caused by a specifi...d group of hematological,malignancies in which the...D is characterised by an excess of blood cells and...
Other Medicine Technology:NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 2NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 3NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 4NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 5S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies 2
...icare's Prep Pads offer convenience, low cost, eas...applications. Each package is terminally sterilize...tient. Sterile Skin Protectant Prep Pads prepare t...dage. When dry, it leaves a thin film on the skin'...
IV Prep Swab Sticks
Triad Plus BZK Swabsticks
...ad Plus PVP-I Prep Swabsticks are saturated with a...to 1% available iodine. Povidone Iodine is vir...branes. It is also non-staining to the skin or nat...s on contact; they are sturdy tools for removing s...
Medicine Products: